- UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients.
UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients.
Oncotarget (2017-11-09)
Corina T Madreiter-Sokolowski, Balázs Győrffy, Christiane Klec, Armin A Sokolowski, Rene Rost, Markus Waldeck-Weiermair, Roland Malli, Wolfgang F Graier
PMID29113301
ZUSAMMENFASSUNG
Cancer cells have developed unique strategies to meet their high energy demand. Therefore, they have established a setting of Ca
MATERIALIEN